PREDICTIVE VALUE OF THE SIGNS AND SYMPTOMS PRECEDING ECLAMPSIA: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/7dc2qz63Keywords:
Delivery, Eclampsia, Magnesium sulphate, Pre-eclampsiaAbstract
Background: Malnutrition can be illness-related (one or more diseases or injuries directly result in nutrient imbalance), or it can be induced by environmental and behavioural variables associated with decreased nutrient intake and/or delivery. Comorbidities were shown to be related with child malnutrition in the study.
Aim: The goal of this study is to showed predictive value of the signs and symptoms preceding eclampsia.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 88 articles, whereas the results of our search on SagePub brought up 43 articles. The results of the search conducted for the last year of 2013 yielded a total 13 articles for PubMed and 7 articles for SagePub. In the end, we compiled a total of 12 papers, 9 of which came from PubMed and 3 of which came from SagePub. We included five research that met the criteria.
Conclusion: Visual abnormalities, epigastric discomfort, and headache are among of the most typically reported symptoms, however none of these were able to effectively predict or rule out the possibility of impending eclampsia.
References
Tranquilli A, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Vol. 4, Pregnancy Hypertension:
An International Journal of Women’s Cardiovascular Health. Elsevier; 2014. p. 97–104.
Peraçoli JC, Borges VTM, Ramos JGL, Cavalli R de C, Costa SH de AM, Oliveira LG de, et al. Preeclampsia/eclampsia. Rev Bras Ginecol e Obs. 2019;41:318–32.
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Heal. 2014 Jun;2(6):e323-33.
Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol. 2005;105(2):402–10.
Luealon P, Phupong V. Risk factors of preeclampsia in Thai women. J Med Assoc Thai. 2010 Jun;93(6):661–6.
Osungbade KO, Ige OK. Review Article Public Health Perspectives of Preeclampsia in Developing Countries : Implication for Health System Strengthening. 2011;2011.
Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies.
Nat Rev Nephrol [Internet] 2019;15(5):275–89. Available from: https://doi.org/10.1038/s41581-019-0119-6
Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, García-May PK, Mhatre M, et al. Preeclampsia and COVID19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021 Sep;225(3):289.e1289.e17.
Bartal MF, Sibai BM. Eclampsia in the 21st century. Am J Obstet Gynecol. 2022;226(2):S1237–53.
Group MTFSC. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for preeclampsia. Outcome for women at 2 years. BJOG An Int J Obstet Gynaecol. 2007;114(3):300–9.
Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022;226(2):S786–803.
Maraschini A, Salvi S, Colciago E, Corsi E, Cetin I, Lovotti M, et al. Eclampsia in Italy: A prospective population-
based study (2017–2020). Pregnancy Hypertens [Internet] 2022;30:204–9. Available from: https://www.sciencedirect.com/science/article/pii/S2210778922001131
Melese MF, Badi MB, Aynalem GL. Perinatal outcomes of severe preeclampsia/eclampsia and associated factors among mothers admitted in Amhara Region referral hospitals, North West Ethiopia, 2018. BMC Res Notes [Internet] 2019;12(1):147. Available from: https://doi.org/10.1186/s13104-019-4161-z
Taweesuk P, Tannirandorn Y. Clinical and laboratory parameters associated with eclampsia in Thai pregnant women. J Med Assoc Thai. 2014;97(2):139–46.
Raghuraman N, March MI, Hacker MR, Modest AM, Wenger J, Narcisse R, et al. Adverse maternal and fetal outcomes and deaths related to preeclampsia and eclampsia in Haiti. Pregnancy Hypertens An Int J Women’s Cardiovasc Heal. 2014;4(4):279–86.
Wiknjosastro H, Prawirohardjo S, Wiknjosastro H, Prawirohardjo S. Ilmu Kebidanan. PT. Bina Pustaka. Jakarta. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo; 2015.
Berhan Y, Berhan A. Should magnesium sulfate be administered to women with mild pre‐eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res. 2015;41(6):831–42.
Task Force on Hypertension in Pregnancy. [Guideline] American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists. Obs Gynecol. 2013;122(5):1122–31.
Fox R, Kitt J, Leeson P, et al. Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring. J Clin Med. 2019;8(10):1625.
Cunningham FG, Leveno KJ, Bloom SL. Williams Obstetri. 25th ed. New York: The McGraw-Hill Companies; 2020.
Lagana AS, Favilli A, Triolo O, et al. Early serum markers of pre-eclampsia: are we stepping forward? J Matern Fetal Neonatal Med. 2015;23:1–5.
Cooray SD, Edmonds SM, Tong S, et al. Characterization of symptoms immediately preceding eclampsia. Obs Gynecol. 2011;118(5):995–9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
